Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

Abstract Background Approximately 2–3% of patients undergoing advanced heart failure therapies such as left ventricular assist devices (LVAD) and orthotropic heart transplantation (OHT) have chemotherapy-related cardiomyopathy, according to analyses of large databases such as United Network for Orga...

Full description

Bibliographic Details
Main Authors: Raquel Araujo-Gutierrez, Sergio H. Ibarra-Cortez, Jerry D. Estep, Arvind Bhimaraj, Ashrith Guha, Imad Hussain, Myung H. Park, Guillermo Torre-Amione, Barry H. Trachtenberg
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Cardio-Oncology
Subjects:
Chemotherapy-induced cardiomyopathy
Anthracyclines
Heart failure
Heart transplantation
Cancer–related cardiomyopathy
Heart transplant
Online Access:http://link.springer.com/article/10.1186/s40959-018-0029-y

Internet

http://link.springer.com/article/10.1186/s40959-018-0029-y

Similar Items